- Home
- VRCA vs FBIO Comparison
VRCA vs FBIO Comparison
Compare VRCA & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRCA
- FBIO
- Stock Information
- Founded
- VRCA 2013
- FBIO 2006
- Country
- VRCA United States
- FBIO United States
- Employees
- VRCA N/A
- FBIO N/A
- Industry
- VRCA Biotechnology: Pharmaceutical Preparations
- FBIO Biotechnology: Pharmaceutical Preparations
- Sector
- VRCA Health Care
- FBIO Health Care
- Exchange
- VRCA Nasdaq
- FBIO Nasdaq
- Market Cap
- VRCA 43.0M
- FBIO 49.1M
- IPO Year
- VRCA 2018
- FBIO N/A
- Fundamental
- Price
- VRCA $0.42
- FBIO $1.69
- Analyst Decision
- VRCA Hold
- FBIO Strong Buy
- Analyst Count
- VRCA 5
- FBIO 3
- Target Price
- VRCA $6.00
- FBIO $21.00
- AVG Volume (30 Days)
- VRCA 243.3K
- FBIO 146.2K
- Earning Date
- VRCA 05-13-2025
- FBIO 05-19-2025
- Dividend Yield
- VRCA N/A
- FBIO N/A
- EPS Growth
- VRCA N/A
- FBIO N/A
- EPS
- VRCA N/A
- FBIO N/A
- Revenue
- VRCA $7,566,000.00
- FBIO $57,675,000.00
- Revenue This Year
- VRCA $127.58
- FBIO $63.20
- Revenue Next Year
- VRCA $88.06
- FBIO $66.70
- P/E Ratio
- VRCA N/A
- FBIO N/A
- Revenue Growth
- VRCA 47.66
- FBIO N/A
- 52 Week Low
- VRCA $0.38
- FBIO $1.33
- 52 Week High
- VRCA $11.41
- FBIO $2.89
- Technical
- Relative Strength Index (RSI)
- VRCA 39.53
- FBIO 52.97
- Support Level
- VRCA $0.45
- FBIO $1.67
- Resistance Level
- VRCA $0.48
- FBIO $1.84
- Average True Range (ATR)
- VRCA 0.04
- FBIO 0.09
- MACD
- VRCA -0.00
- FBIO 0.01
- Stochastic Oscillator
- VRCA 22.13
- FBIO 58.54
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.